Anavex Life Sciences
AVXL
#7719
Rank
NZ$0.61 B
Marketcap
NZ$6.93
Share price
-2.19%
Change (1 day)
-50.93%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -NZ$87.97 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$88.84 Million a decrease over its 2023 earnings that were of -NZ$77.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$87.97 Million-0.97%
2024 -NZ$88.84 Million14.77%
2023 -NZ$77.41 Million-17.49%
2022 -NZ$93.81 Million22.96%
2021 -NZ$76.29 Million35.36%
2020 -NZ$56.37 Million12.65%
2019 -NZ$50.03 Million29.09%
2018 -NZ$38.76 Million36.33%
2017 -NZ$28.43 Million17.11%
2016 -NZ$24.28 Million20.91%
2015 -NZ$20.08 Million-6.29%
2014 -NZ$21.43 Million337.28%
2013 -NZ$4.9 Million
2008 -NZ$9.07 Million106.01%
2007 -NZ$4.4 Million8848.98%
2006 -NZ$0.05 Million-79.99%
2005 -NZ$0.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$0.11 B-228.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$11.41 Million-87.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$0.11 B-225.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$29.8 Million-66.78%๐Ÿ‡บ๐Ÿ‡ธ USA